Implication of intestinal barrier dysfunction in gut dysbiosis and diseases
The intestinal mucosal barrier, also referred to as intestinal barrier, is widely recognized as a
critical player in gut homeostasis maintenance as it ensures the complex crosstalk between …
critical player in gut homeostasis maintenance as it ensures the complex crosstalk between …
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
Mucus is a viscoelastic and adhesive gel that protects the lung airways, gastrointestinal (GI)
tract, vagina, eye and other mucosal surfaces. Most foreign particulates, including …
tract, vagina, eye and other mucosal surfaces. Most foreign particulates, including …
Enzymatically active biomimetic micropropellers for the penetration of mucin gels
D Walker, BT Käsdorf, HH Jeong, O Lieleg… - Science …, 2015 - science.org
In the body, mucus provides an important defense mechanism by limiting the penetration of
pathogens. It is therefore also a major obstacle for the efficient delivery of particle-based …
pathogens. It is therefore also a major obstacle for the efficient delivery of particle-based …
Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier
Protective mucus coatings typically trap and rapidly remove foreign particles from the eyes,
gastrointestinal tract, airways, nasopharynx, and female reproductive tract, thereby strongly …
gastrointestinal tract, airways, nasopharynx, and female reproductive tract, thereby strongly …
Mucus as a barrier to lipophilic drugs
HH Sigurdsson, J Kirch, CM Lehr - International journal of pharmaceutics, 2013 - Elsevier
Mucus is a complex hydrogel, comprising glycoproteins, lipids, salts, DNA, enzymes and
cellular debris, covering many epithelial surfaces in the human body. Once secreted, mucin …
cellular debris, covering many epithelial surfaces in the human body. Once secreted, mucin …
Pulmonary delivery nanomedicines towards circumventing physiological barriers: Strategies and characterization approaches
Pulmonary delivery of nanomedicines is very promising in lung local disease treatments
whereas several physiological barriers limit its application via the interaction with inhaled …
whereas several physiological barriers limit its application via the interaction with inhaled …
Highly compacted biodegradable DNA nanoparticles capable of overcoming the mucus barrier for inhaled lung gene therapy
P Mastorakos, AL Da Silva… - Proceedings of the …, 2015 - National Acad Sciences
Gene therapy has emerged as an alternative for the treatment of diseases refractory to
conventional therapeutics. Synthetic nanoparticle-based gene delivery systems offer highly …
conventional therapeutics. Synthetic nanoparticle-based gene delivery systems offer highly …
New and emerging targeted therapies for cystic fibrosis
BS Quon, SM Rowe - Bmj, 2016 - bmj.com
Cystic fibrosis (CF) is a monogenic autosomal recessive disorder that affects about 70 000
people worldwide. The clinical manifestations of the disease are caused by defects in the …
people worldwide. The clinical manifestations of the disease are caused by defects in the …
[HTML][HTML] Developments of mucus penetrating nanoparticles
Mucus can effectively protect the exposed mucosal surfaces due to its adhesive and
viscoelastic properties. Most foreign particulates are efficiently trapped in mucus layers via …
viscoelastic properties. Most foreign particulates are efficiently trapped in mucus layers via …
Enhanced viscoelasticity of human cystic fibrotic sputum correlates with increasing microheterogeneity in particle transport
Current biochemical characterizations of cystic fibrosis (CF) sputum do not address the high
degree of microheterogeneity in the rheological properties of the mucosal matrix and only …
degree of microheterogeneity in the rheological properties of the mucosal matrix and only …